5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
about
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptorsEffect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI StudiesDopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptorsSerotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?Classics in Chemical Neuroscience: Aripiprazole.Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.Ziprasidone: the fifth atypical antipsychotic.5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes.Effects of gastrodia elata bl on phencyclidine-induced schizophrenia-like psychosis in mice.Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.Discovery of Natural Product-Derived 5-HT1A Receptor Binders by Cheminfomatics Modeling of Known Binders, High Throughput Screening and Experimental Validation.Ziprasidone: a novel psychotropic with unique properties.The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsAdjunct mirtazapine for negative symptoms of schizophrenia.Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine.Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem.Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism.Development of CNS multi-receptor ligands: Modification of known D2 pharmacophoresAtypical antipsychotics in the therapy of bipolar disorders: efficacy and safety.Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia.Effects of clozapine on the efflux of serotonin and dopamine in the rat brain: the role of 5-HT1A receptors.A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.Occupancy of agonist drugs at the 5-HT1A receptor.N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.Ziprasidone-induced spontaneous orgasm.SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder.Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study.
P2860
Q24564963-EE38A4EF-2374-45C6-9D18-5816067DD699Q24672474-5041EC5A-9A92-4062-98F5-FAC945A4CC86Q26744718-9C61C54A-6E29-4AE9-8326-1F842AA2A589Q28273285-CE6AD1E6-EA34-471A-B3CE-04031796ED28Q30445192-D49CBA2E-ADE6-4FF9-9CAF-38D4CFDB74DBQ30493133-F2554D4F-4598-4A53-853E-EB5D5DFF410AQ30984472-88E3EFB8-C55D-40A1-ACA9-F663DBEE3A60Q32134744-82F37715-4AA1-4C08-99AB-DA6423EB3B60Q33845251-2042D881-5291-4B73-8553-578377A59515Q33866125-D4A291B6-4C47-4583-ACA3-207ABAAB3069Q34169978-9D715B0F-52D4-4DD3-9F2F-1B92EE31B275Q34350194-F1B9DB06-518C-4C1B-A028-0BF04B759000Q34615595-FCF3A6F6-33CC-4492-B83B-D5407032C71BQ34619843-2E7CA777-299F-4CE1-9447-6A8B6D6E6DB8Q35107849-83A9AB1F-EA7C-44F5-8968-EAE96E8F0559Q35179039-F75D3DA8-9335-48BE-9A79-CD46347916CAQ35681838-83265337-F78C-48DF-BF4F-69735B78872CQ36107060-CD991113-2940-467D-9673-58AD0C5E40C8Q36534965-77ED2AF0-C7D3-4008-8577-BB255A37F574Q37939248-BE82AE8C-7FF9-4985-AE19-EFD13E4BFBB1Q38062443-ACABD184-405E-41E5-9938-E21BF08D8B42Q38284625-5D451EFA-487F-4EF7-A979-1E5E5C1F7E61Q39036691-801BB7E7-2503-4420-A3E8-960E1D713A8FQ39271592-B8FE07EF-BF49-460A-9824-68FABDD262D1Q40494872-B43541DB-9342-4FA4-A5C5-BBC0CC7541FAQ40626733-CC0E8CD0-91BA-4E41-8828-38A2FC4CB915Q40644004-D5E08B2C-7211-431B-81CD-D34FEA81B19DQ41967962-D69A8BDE-B646-4605-9839-A56408CE6CFBQ42445739-19B7D7D4-6B5A-4A41-92C3-2B12F28B4019Q43170052-75CB8E69-C541-4DF3-A19D-0569618ADB2EQ44300915-9BCF9F0F-2D19-434A-8FC0-9C0B92C5FB10Q44381875-75BB59C2-5138-40F1-BCBF-CBB5D736739BQ44393719-A9BC330B-2272-43B2-8281-050AD03FEAE5Q44777682-25B95813-62DA-43E2-A19C-1F86A52C3D0BQ46017960-DD5F8A56-D9DE-4B0D-B98F-D4ECBE64839FQ46150841-A567B1CA-E9A3-46A1-A30B-D853AF922731Q46248926-557ABA63-4434-45F6-8B64-71870BFA5092Q47147496-4B3D1BEF-396D-4542-BBF0-4816941E52D0Q47602688-3652434D-BE2D-4DA3-A253-F2B8F17F18D2Q48684926-92D2BB43-0F60-4D84-817F-2B48F030052F
P2860
5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@ast
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@en
type
label
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@ast
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@en
prefLabel
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@ast
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@en
P2093
P1476
5-HT(1A) receptor activation c ...... in the rat prefrontal cortex.
@en
P2093
P304
P356
10.1016/S0006-3223(00)00850-7
P407
P577
2000-08-01T00:00:00Z